Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Quantification of the Antidyskinetic Effect of Amantadine and Topiramate in Parkinson's Disease

NCT00794313 is registered in ClinicalTrials.gov with Oregon Health and Science University as lead sponsor.

NCT NCT00794313
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00794313 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Quantification of the Antidyskinetic Effect of Amantadine and Topiramate in Parkinson's Disease
Lead sponsor
Oregon Health and Science University
Phase
Not applicable
Overall status
Terminated
Start date
September 30, 2009
Completion date
June 30, 2010
Enrollment
3 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson's disease